Precigen (PGEN) Net Income (2012 - 2026)
Precigen's (PGEN) quarterly Net Income came in at -$7.9 million in Q1 2026, up 85.36% year-on-year from -$4.3 million in Q1 2025, and up 66.26% on a QoQ basis from -$23.5 million in Q4 2025.
Precigen (PGEN) Net Income (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 14 years of Net Income data on file, last reported at -$7.9 million in Q1 2026.
- On a quarterly basis, Net Income rose 85.36% year-over-year to -$7.9 million in Q1 2026; TTM through Mar 2026 was -$204.4 million, a 30.49% decrease from a year earlier, with the FY2025 full-year figure at -$250.6 million, changed N/A from the prior year.
- Net Income for Q1 2026 stood at -$7.9 million, up from -$23.5 million in the prior quarter.
- Over the last five years, Net Income for PGEN reached as high as $95.0 million in Q3 2022 and fell as low as -$146.3 million in Q3 2025.
- Historically, Net Income has averaged -$23.1 million across 4 years, with a median of -$23.6 million in 2024.
- Across the five-year window, Net Income soared 2858.29% in 2022 and slumped 510.33% in 2025, its largest moves.
- Year by year, Net Income stood at $95.0 million in 2022, then tumbled by 120.76% to -$19.7 million in 2024, then fell by 19.14% to -$23.5 million in 2025, then soared by 66.26% to -$7.9 million in 2026.
- Per Business Quant data, the three most recent Net Income figures were -$7.9 million in Q1 2026, -$23.5 million in Q4 2025, and -$146.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | -7.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.93 Mn |
| Dec 31, 2025 | -23.50 Mn |
| Sep 30, 2025 | -146.34 Mn |
| Jun 30, 2025 | -26.64 Mn |
| Mar 31, 2025 | -54.15 Mn |
| Dec 31, 2024 | -19.73 Mn |
| Sep 30, 2024 | -23.98 Mn |
| Jun 30, 2024 | -58.79 Mn |
| Mar 31, 2024 | -23.74 Mn |
| Sep 30, 2022 | 95.02 Mn |
| Jun 30, 2022 | 8.42 Mn |
| Mar 31, 2022 | 4.65 Mn |
| Dec 31, 2021 | 1.66 Mn |
| Sep 30, 2021 | -3.45 Mn |
| Jun 30, 2021 | 10.89 Mn |
| Mar 31, 2021 | 4.53 Mn |
| Dec 31, 2020 | -1.31 Mn |
| Sep 30, 2020 | -1.97 Mn |
| Jun 30, 2020 | -27.65 Mn |
| Mar 31, 2020 | -35.15 Mn |